Paratek Pharmaceuticals is a biopharmaceutical company that develops and commercializes life-saving therapies for civilian, government, and military use to cure life-threatening diseases and public health threats. Its lead products, NUZYRA and SEYSARA, are used as antibiotics to treat skin infections and moderate to severe acne vulgaris. Paratek Pharmaceuticals has several license agreements and collaborations with Tufts University, Allergan plc, and Biomedical Advanced Research and Development Authority.